These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 72782)

  • 41. Alternative pathways of T lymphocyte activation.
    Bach FH; Alter BJ
    J Exp Med; 1978 Sep; 148(3):829-34. PubMed ID: 100571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic control of the immune response to myoglobins. Both low and high responder T cells tolerant to the other major histocompatibility complex help high but not low responder B cells.
    Kohno Y; Berzofsky JA
    J Exp Med; 1982 Sep; 156(3):791-809. PubMed ID: 6213732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Major histocompatibility complex-restricted and unrestricted T helper cells recognizing minor histocompatibility antigens of B cell surfaces.
    Coutinho A; Augustin AA
    Eur J Immunol; 1980 Jul; 10(7):535-41. PubMed ID: 6157541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by H-2K and H-2D serological regions of the murine major histocompatibility complex.
    Shearer GM; Rehn TG; Garbarino CA
    J Exp Med; 1975 Jun; 141(6):1348-64. PubMed ID: 47900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity.
    Gracie JA; Bolton EM; Porteous C; Bradley JA
    J Exp Med; 1990 Dec; 172(6):1547-57. PubMed ID: 2258695
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T-cell responses to minor histocompatibility antigens.
    Lai PK; Waterfield JD; Gascoigne NR; Sharrock CE; Mitchison NA
    Immunology; 1982 Oct; 47(2):371-81. PubMed ID: 6214502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of a clonal assay for cytotoxic T lymphocytes to determine the Ly phenotypes of the cytotoxic precursor and effector cells to alloantigens and trinitrophenyl-modified self antigens.
    Teh HS; Teh SJ
    J Immunol; 1980 Nov; 125(5):1977-86. PubMed ID: 6159396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-idiotypic cytotoxic T cells in rats with graft-versus-host disease.
    Kimura H; Wilson DB
    Nature; 1984 Mar 29-Apr 4; 308(5958):463-4. PubMed ID: 6608695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recognitive specificity of human cytotoxic T lymphocytes. I. Antigen-specific inhibition of human cell-mediated lympholysis.
    Sondel PM; Bach FH
    J Exp Med; 1975 Dec; 142(6):1339-48. PubMed ID: 53262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The mouse-primed lymphocyte typing test. III. Dissociation of T lymphocyte-stimulating determinants and antibody-defined specificities of the I region-associated Ia antigens.
    Peck AB; Klein J; Wigzell H
    J Immunol; 1980 Sep; 125(3):1978-86. PubMed ID: 6157729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytotoxic T lymphocytes induced against allogeneic I-region determinants react with Ia molecules on trinitrophenyl-conjugated syngeneic target cells.
    Billings P; Burakoff S; Dorf ME; Benacerraf B
    J Exp Med; 1977 Aug; 146(2):623-8. PubMed ID: 69009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thymic influence on the T-lymphocyte self MHC repertoire. II. Cytotoxic T-lymphocyte precursors.
    Jenski LJ; Miller BA
    Thymus; 1988; 11(3):151-71. PubMed ID: 3259029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
    Mizuochi T; Ono S; Malek TR; Singer A
    J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming.
    Bevan MJ
    J Immunol; 1976 Dec; 117(6):2233-8. PubMed ID: 825578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for identity or close association of the Fc receptor of B lymphocytes and alloantigens determined by the Ir region of the H-2 complex.
    Dickler HB; Sachs DH
    J Exp Med; 1974 Sep; 140(3):779-96. PubMed ID: 4137653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. H-2D products do not affect lysis of Kk target cells by Kk-specific cytotoxic T cells.
    Teh HS; Romaniuk R; Von Boehmer H
    Eur J Immunol; 1983 Mar; 13(3):259-61. PubMed ID: 6601017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences in surface phenotype between cytolytic and non-cytolytic CD4+ T cells. MHC class II-specific cytotoxic T lymphocytes lack Leu 8 antigen and express CD2 in high density.
    Takada S; Koide J; Engleman EG
    J Immunol; 1989 May; 142(9):3038-44. PubMed ID: 2468710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The biologic significance of alloreactivity. The ontogeny of T-cell sets specific for alloantigens or modified self antigens.
    Burakoff SJ; Finberg R; Glimcher L; Lemonnier F; Benacerraf B; Cantor H
    J Exp Med; 1978 Nov; 148(5):1414-22. PubMed ID: 214510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
    Rosenberg AS; Katz SI; Singer A
    J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.